{"entities": {"urls": [{"start": 128, "end": 151, "url": "https://t.co/9kf6sAU9RJ", "expanded_url": "https://www.globenewswire.com/news-release/2020/05/26/2038598/0/en/Diffusion-Pharmaceuticals-Receives-Accelerated-FDA-Response-to-Proposed-TSC-COVID-19-Clinical-Trial-Program.html", "display_url": "globenewswire.com/news-release/2\u2026"}], "annotations": [{"start": 29, "end": 53, "probability": 0.4198, "type": "Organization", "normalized_text": "DIFFUSION PHARMACEUTICAL"}, {"start": 71, "end": 73, "probability": 0.7532, "type": "Organization", "normalized_text": "FDA"}], "mentions": [{"start": 0, "end": 11, "username": "WhiteHouse", "id": "1323730225067339784"}]}, "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "88", "name": "Political Body", "description": "A section of a government, like The Supreme Court"}, "entity": {"id": "871795678447456256", "name": "The White House", "description": "Conversation from and about the White House, both as a destination and as political voice"}}], "author_id": "3310124155", "id": "1265361090503942148", "possibly_sensitive": false, "lang": "en", "in_reply_to_user_id": "822215673812119553", "conversation_id": "1265360839646892037", "created_at": "2020-05-26T19:16:07.000Z", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "reply_settings": "everyone", "text": "@WhiteHouse BREAKING NEWS!!!!\nDIFFUSION PHARMACEUTICAL (DFFN) receives FDA Accelerated Response for it's Covid-19 treatment!!!!\nhttps://t.co/9kf6sAU9RJ", "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1265360839646892037"}]}